Daftar Pustaka Pola Kuman Dan Resistensinya Pada Pasien Sepsis Dewasa Terhadap Antibiotik Di RSUD Dr. Moewardi Tahun 2014.
28
Daftar Pustaka
Abe, R., Oda, S., Sadahiro, T., Nakamura, M., Hirayama, Y., Tateishi, Y., et al.,
2010, Gram-negative bacteremia induces greater magnitude of inflammatory
response than Gram-positive bacteremia, Critical Care, 14, 1-7
Archer, G. L. & Climo, M. W., 1994, Antimicrobial Susceptibility of CoagulaseNegative Staphylococci, Antimicrobial Agents and Chemotherapy, 38 (10),
2231–2237
Artero, A., Zaragoza, R., & Nogueira, J. M., 2012, Epidemiology of Severe Sepsis
and Septic Shock R. Fernandez, Croatia: In Tech
Berkowitz, D.M., & Martin, G.S., 2007, Sepsis and Sex Can We Look Beyond Our
Hormones?, Chest, 132 (6), 1725–1727
Bion, J. F., Buisson, C. B., Chastre, J., Elliot, T. S. J., Gant, V., Glen, L., et al., 2001,
Antibiotic Resistance and Infection Control. In: Galley, H. F. (ed.) Critical
Care Focus 5, fifth ed., London, BMJ Books
Cabell, C. H., Abrutyn, E., & Karchmer, A. W., 2003, Bacterial Endocarditis: The
disease, treatment, and prevention, Circulation, 107 (20), e185–e187
Cayono, J.B.S.B., 2007, Terepi Antibiotik Empiris pada Sepsis Berdasarkan Organ
Terinfeksi, Jurnal Kedokteran dan Farmasi, 20 (2), 85–90
CDC, 2003, Manual for the Laboratory Identification and Antimicrobial
Susceptibility Testing of Bacterial Pathogens of Public Health Importance in the
Developing World, 134-135, USA, Center for Disease Control and Prevention
CDC, 2013, Antibiotic Resistance Threats in the United States 2013, US, US
Department of Health and Human Services
Chairunnisa S. Dian, 2012, Pola Penggunaan Antibiotik dan Pola Kuman pada Pasien
Sepsis Rawat Inap RSUP Dr. Hasan Sadikin Bandung, Skripsi, Fakultas
Farmasi, Universitas Padjajaran
Chen, C. J., & Huang, Y. C., 2014, New epidemiology of Staphylococcus aureus
infection in Asia, Clinical Microbiology and Infection, 20, 605–623
Cunha, B. A., 2008, Sepsis and septic shock: selection of empiric antimicrobial
therapy. Critical Care Clinics, 24 (2), 313–334
29
Daniela, M. L., 2010, Paediatric Sepsis diagnosis, ethiology, evolution, Thesis,
Faculty of General Medicine, University of Medicine and Pharmacy Craiova
Dipiro et al., 2008, Pharmacotherapy A Pathophysiologic Approach, Seventh
Edition, 1949, New York, McGraw-Hill
Duerink, D. O., Lestari, Endang S., Hadi, U., Nagelkerke, Nico J. D., Verbrugh,
Henri A., Keuter, M., et al., 2007, Determinants of carriage of resistant
Escherichia coli in the Indonesian population inside and outside hospitals,
Journal of Antimicrobial Chemotherapy, 60, 377–384
Gatermann, S.G., Koschinski, T. & Friedrich, S., 2007, Distribution and expression
of macrolide resistance genes in coagulase-negative Staphylococci, Clinical
Microbiology and Infection, 13, 777–781
Gillani, W. S., Sulaiman, A. S., & Nejad, F. B., 2009, Antibiotic resistance and
therapeutic management of sepsis in a Malaysian public Hospital, Australasian
Medical Journal, 1 (14), 244–245
Guilfoile, P. G., 2007, Antibiotic-Resistant Bacteria. In: Alcamo, I. E. (ed.) Deadly
Disease and Epidemics, New York, Chelsea House
Hancock, R. E. W., & Speert, D. P., 2000, Antibiotic resistance in Pseudomonas
aeruginosa: mechanisms and impact on treatment, Drug Resistance Updates, 3,
247–255
Hawkley, L. C., & Cacioppo, J. T., 2004, Stress and the aging immune system, Brain,
Behavior, and Immunity, 18 (2), 114–119
Hooper, D. C., 2000, Mechanisms of Action and Resistance of Older and Newer
Fluoroquinolones, Clinical Infectious Diseases, 31 (Suppl 2), S24-S28
Hoyert, D. L., Arias, E., Smith, B. L., Murphy, S. L., Kochanek, K. D., et al., 2001,
Deaths: Final Data for 1999, National Vital Statistics Report, 49
Huebner, J. & Goldmann, D. A., 1999, Coagulase-negative staphylococci: role as
pathogens, Annual Review of Medicine, 50, 223–236
Ibrahim, N.L., 2014, TNF : A signaling pathway related to the activation of NF- κB,
UK Journal of Pharmaceutical and Biosciences, 2 (3), 21–24
30
John, J. F. & Harvin, A. M., 2007, History and evolution of antibiotic resistance in
coagulase-negative staphylococci : Susceptibility profiles of new antistaphylococcal agents, Therapeutics and Clinical Risk Management, 3 (14),
1143–1152
Kocsis, B. & Szabó, D., 2013, Antibiotic resistance mechanisms in
Enterobacteriaceae. In: A. Méndez-Vilas (ed.) Microbial pathogens and
strategies for combating them: science, technology and education. Spain,
Formatex
Lambert, P. A., 2002, Mechanisms of antibiotic resistance in Pseudomonas
aeruginosa, Journal of the Royal Society of Medicine, 95 (Suppl. 4), 22-26
Laraki, N., Franceschini, N., Rossolini, G. M., Santucci, P., Meunier, C., de Pauw, E.,
et al., 1999, Biochemical Characterization of the Pseudomonas aeruginosa
101/1477 Metallo beta Lactamase IMP-1 Produced by Escherichia coli,
Antimicrobial Agents and Chemotherapy, 43, 902–906
Lewis, M. T., Biedenbach, D. J. & Jones, R. N., 1999, In Vitro Evaluation of
Cefepime and Other Broad-Spectrum beta -Lactams Against Bacteria from
Indonesian Medical Centers The Indonesia Antimicrobial Resistance Study,
Diagnostic Microbiology Infectious Disease , 8893 (99), 285–290
Ligozzi, M., Bernini, C., Bonora, M. G., de Fatima, M., Zuliani, J., Fontana, R., 2002,
Evaluation of the VITEK 2 System for Identification and Antimicrobial
Susceptibility Testing of Medically Relevant Gram-Positive Cocci, Journal of
Clinical Microbiology, 40 (5), 1681–1686
Lowy, F. D., 2003, Antimicrobial resistance: the example of Staphylococcus aureus,
Journal of Clinical Investigation, 111 (9), 1265–1273
Maragakis, L. L., & Perl, T. M., 2008, Acinetobacter baumannii: epidemiology,
antimicrobial resistance, and treatment options, Clinical Infectious Diseases, 46
(8), 1254–1263
Morrell, M. R., Micek, S. T., & Kollef, M. H., 2009, The management of severe
sepsis and septic shock, Infectious disease clinics of North America, 23 (3), 485–
501
Moloughney, J. G., Thomas, J. D., & Toney, J. H., 2005, Novel IMP-1 metallo-βlactamase inhibitors can reverse meropenem resistance in Escherichia coli
expressing IMP-1, FEMS Microbiology Letters, 243, 65–71
31
Ntusi, N., Aubin, L., Oliver, S., Whitelaw, A., Mendelson, M., 2010, Guideline for
the optimal use of blood cultures, South African Medical Journal, 100 (12),
839–843
Otto, M., 2008, Staphylococcal Biofilm, Curr Top Microbiol Immunol, 322, 207–228
Radji, M., Fauziah, S., & Aribinuko, N., 2011, Antibiotic sensitivity pattern of
bacterial pathogens in the intensive care unit of Fatmawati Hospital, Indonesia,
Asian Pacific journal of tropical biomedicine, 1 (1), 39–42
Sandiana, Ajeng T., 2012, Pola Penggunaan Antibiotik dan Pola Kuman pada Pasien
Sepsis di Salah Satu Rumah Sakit Swasta di Kota Bandung, Skripsi, Fakultas
Farmasi, Universitas Padjajaran
Soedarmo, S. S. P., Garna, H., Hadinegoro, S. R. S., & Satari, H. I., 2008, Buku Ajar
Infeksi & Pediatri Tropis, Edisi Kedua, 362, Jakarta, Ikatan Dokter Anak
Indonesia
Southwick, Frederick S., 2007, Infectious Disease A Clinical Shourt Course, Second
Edition, 63, USA, McGraw-Hill
SWAB, 2010, SWAB guidelines for Antibacterial Antibacterial therapy of adult
patients with Sepsis, 1-86, Netherland, Stichting Werkgroep Antibioticabeled
Vila, J., Ruiz, J., Goni, P., Angeles, M., de Anta, T. J., 1995, Mutation in the gyrA
gene of quinolone-resistant clinical isolates of Acinetobacter baumannii,
Antimicrobial Agents and Chemotherapy, 39 (5), 1201–1203
Vila, J., Ruiz, J., Goni, P., Angeles, M., de Anta, T. J., 1997, Quinolone-resistance
mutations in the topoisomerase IV, Journal of Antimicrobial Chemotherapy, 39,
757–762
WHO, 2001, Infections and infectious diseases A manual for nurses and midwives in
the WHO European Region, 13, Europe, World Health Organization
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., et al., 1998, IL6 is an antiinflammatory cytokine required for controlling local or systemic
acute inflammatory responses, The Journal of Clinical Investigation, 101(2),
311–320
Zheng, Z., & Stewart, P. S., 2002, Penetration of Rifampin through Staphylococcus
epidermidis Biofilms, Antimicrobial Agents and Chemotherapy, 46 (3), 900–903
32
Ziebuhr, W., Krimmer, V., Rachid, S., Loßner, I., Got, F., 1999, A novel mechanism
of phase variation of virulence in Staphylococcus epidermidis : evidence for
control of the polysaccharide intercellular adhesin synthesis by alternating
insertion and excision of the insertion sequence element IS256, Molecular
Microbiology, 32 (2), 345–356
Daftar Pustaka
Abe, R., Oda, S., Sadahiro, T., Nakamura, M., Hirayama, Y., Tateishi, Y., et al.,
2010, Gram-negative bacteremia induces greater magnitude of inflammatory
response than Gram-positive bacteremia, Critical Care, 14, 1-7
Archer, G. L. & Climo, M. W., 1994, Antimicrobial Susceptibility of CoagulaseNegative Staphylococci, Antimicrobial Agents and Chemotherapy, 38 (10),
2231–2237
Artero, A., Zaragoza, R., & Nogueira, J. M., 2012, Epidemiology of Severe Sepsis
and Septic Shock R. Fernandez, Croatia: In Tech
Berkowitz, D.M., & Martin, G.S., 2007, Sepsis and Sex Can We Look Beyond Our
Hormones?, Chest, 132 (6), 1725–1727
Bion, J. F., Buisson, C. B., Chastre, J., Elliot, T. S. J., Gant, V., Glen, L., et al., 2001,
Antibiotic Resistance and Infection Control. In: Galley, H. F. (ed.) Critical
Care Focus 5, fifth ed., London, BMJ Books
Cabell, C. H., Abrutyn, E., & Karchmer, A. W., 2003, Bacterial Endocarditis: The
disease, treatment, and prevention, Circulation, 107 (20), e185–e187
Cayono, J.B.S.B., 2007, Terepi Antibiotik Empiris pada Sepsis Berdasarkan Organ
Terinfeksi, Jurnal Kedokteran dan Farmasi, 20 (2), 85–90
CDC, 2003, Manual for the Laboratory Identification and Antimicrobial
Susceptibility Testing of Bacterial Pathogens of Public Health Importance in the
Developing World, 134-135, USA, Center for Disease Control and Prevention
CDC, 2013, Antibiotic Resistance Threats in the United States 2013, US, US
Department of Health and Human Services
Chairunnisa S. Dian, 2012, Pola Penggunaan Antibiotik dan Pola Kuman pada Pasien
Sepsis Rawat Inap RSUP Dr. Hasan Sadikin Bandung, Skripsi, Fakultas
Farmasi, Universitas Padjajaran
Chen, C. J., & Huang, Y. C., 2014, New epidemiology of Staphylococcus aureus
infection in Asia, Clinical Microbiology and Infection, 20, 605–623
Cunha, B. A., 2008, Sepsis and septic shock: selection of empiric antimicrobial
therapy. Critical Care Clinics, 24 (2), 313–334
29
Daniela, M. L., 2010, Paediatric Sepsis diagnosis, ethiology, evolution, Thesis,
Faculty of General Medicine, University of Medicine and Pharmacy Craiova
Dipiro et al., 2008, Pharmacotherapy A Pathophysiologic Approach, Seventh
Edition, 1949, New York, McGraw-Hill
Duerink, D. O., Lestari, Endang S., Hadi, U., Nagelkerke, Nico J. D., Verbrugh,
Henri A., Keuter, M., et al., 2007, Determinants of carriage of resistant
Escherichia coli in the Indonesian population inside and outside hospitals,
Journal of Antimicrobial Chemotherapy, 60, 377–384
Gatermann, S.G., Koschinski, T. & Friedrich, S., 2007, Distribution and expression
of macrolide resistance genes in coagulase-negative Staphylococci, Clinical
Microbiology and Infection, 13, 777–781
Gillani, W. S., Sulaiman, A. S., & Nejad, F. B., 2009, Antibiotic resistance and
therapeutic management of sepsis in a Malaysian public Hospital, Australasian
Medical Journal, 1 (14), 244–245
Guilfoile, P. G., 2007, Antibiotic-Resistant Bacteria. In: Alcamo, I. E. (ed.) Deadly
Disease and Epidemics, New York, Chelsea House
Hancock, R. E. W., & Speert, D. P., 2000, Antibiotic resistance in Pseudomonas
aeruginosa: mechanisms and impact on treatment, Drug Resistance Updates, 3,
247–255
Hawkley, L. C., & Cacioppo, J. T., 2004, Stress and the aging immune system, Brain,
Behavior, and Immunity, 18 (2), 114–119
Hooper, D. C., 2000, Mechanisms of Action and Resistance of Older and Newer
Fluoroquinolones, Clinical Infectious Diseases, 31 (Suppl 2), S24-S28
Hoyert, D. L., Arias, E., Smith, B. L., Murphy, S. L., Kochanek, K. D., et al., 2001,
Deaths: Final Data for 1999, National Vital Statistics Report, 49
Huebner, J. & Goldmann, D. A., 1999, Coagulase-negative staphylococci: role as
pathogens, Annual Review of Medicine, 50, 223–236
Ibrahim, N.L., 2014, TNF : A signaling pathway related to the activation of NF- κB,
UK Journal of Pharmaceutical and Biosciences, 2 (3), 21–24
30
John, J. F. & Harvin, A. M., 2007, History and evolution of antibiotic resistance in
coagulase-negative staphylococci : Susceptibility profiles of new antistaphylococcal agents, Therapeutics and Clinical Risk Management, 3 (14),
1143–1152
Kocsis, B. & Szabó, D., 2013, Antibiotic resistance mechanisms in
Enterobacteriaceae. In: A. Méndez-Vilas (ed.) Microbial pathogens and
strategies for combating them: science, technology and education. Spain,
Formatex
Lambert, P. A., 2002, Mechanisms of antibiotic resistance in Pseudomonas
aeruginosa, Journal of the Royal Society of Medicine, 95 (Suppl. 4), 22-26
Laraki, N., Franceschini, N., Rossolini, G. M., Santucci, P., Meunier, C., de Pauw, E.,
et al., 1999, Biochemical Characterization of the Pseudomonas aeruginosa
101/1477 Metallo beta Lactamase IMP-1 Produced by Escherichia coli,
Antimicrobial Agents and Chemotherapy, 43, 902–906
Lewis, M. T., Biedenbach, D. J. & Jones, R. N., 1999, In Vitro Evaluation of
Cefepime and Other Broad-Spectrum beta -Lactams Against Bacteria from
Indonesian Medical Centers The Indonesia Antimicrobial Resistance Study,
Diagnostic Microbiology Infectious Disease , 8893 (99), 285–290
Ligozzi, M., Bernini, C., Bonora, M. G., de Fatima, M., Zuliani, J., Fontana, R., 2002,
Evaluation of the VITEK 2 System for Identification and Antimicrobial
Susceptibility Testing of Medically Relevant Gram-Positive Cocci, Journal of
Clinical Microbiology, 40 (5), 1681–1686
Lowy, F. D., 2003, Antimicrobial resistance: the example of Staphylococcus aureus,
Journal of Clinical Investigation, 111 (9), 1265–1273
Maragakis, L. L., & Perl, T. M., 2008, Acinetobacter baumannii: epidemiology,
antimicrobial resistance, and treatment options, Clinical Infectious Diseases, 46
(8), 1254–1263
Morrell, M. R., Micek, S. T., & Kollef, M. H., 2009, The management of severe
sepsis and septic shock, Infectious disease clinics of North America, 23 (3), 485–
501
Moloughney, J. G., Thomas, J. D., & Toney, J. H., 2005, Novel IMP-1 metallo-βlactamase inhibitors can reverse meropenem resistance in Escherichia coli
expressing IMP-1, FEMS Microbiology Letters, 243, 65–71
31
Ntusi, N., Aubin, L., Oliver, S., Whitelaw, A., Mendelson, M., 2010, Guideline for
the optimal use of blood cultures, South African Medical Journal, 100 (12),
839–843
Otto, M., 2008, Staphylococcal Biofilm, Curr Top Microbiol Immunol, 322, 207–228
Radji, M., Fauziah, S., & Aribinuko, N., 2011, Antibiotic sensitivity pattern of
bacterial pathogens in the intensive care unit of Fatmawati Hospital, Indonesia,
Asian Pacific journal of tropical biomedicine, 1 (1), 39–42
Sandiana, Ajeng T., 2012, Pola Penggunaan Antibiotik dan Pola Kuman pada Pasien
Sepsis di Salah Satu Rumah Sakit Swasta di Kota Bandung, Skripsi, Fakultas
Farmasi, Universitas Padjajaran
Soedarmo, S. S. P., Garna, H., Hadinegoro, S. R. S., & Satari, H. I., 2008, Buku Ajar
Infeksi & Pediatri Tropis, Edisi Kedua, 362, Jakarta, Ikatan Dokter Anak
Indonesia
Southwick, Frederick S., 2007, Infectious Disease A Clinical Shourt Course, Second
Edition, 63, USA, McGraw-Hill
SWAB, 2010, SWAB guidelines for Antibacterial Antibacterial therapy of adult
patients with Sepsis, 1-86, Netherland, Stichting Werkgroep Antibioticabeled
Vila, J., Ruiz, J., Goni, P., Angeles, M., de Anta, T. J., 1995, Mutation in the gyrA
gene of quinolone-resistant clinical isolates of Acinetobacter baumannii,
Antimicrobial Agents and Chemotherapy, 39 (5), 1201–1203
Vila, J., Ruiz, J., Goni, P., Angeles, M., de Anta, T. J., 1997, Quinolone-resistance
mutations in the topoisomerase IV, Journal of Antimicrobial Chemotherapy, 39,
757–762
WHO, 2001, Infections and infectious diseases A manual for nurses and midwives in
the WHO European Region, 13, Europe, World Health Organization
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., et al., 1998, IL6 is an antiinflammatory cytokine required for controlling local or systemic
acute inflammatory responses, The Journal of Clinical Investigation, 101(2),
311–320
Zheng, Z., & Stewart, P. S., 2002, Penetration of Rifampin through Staphylococcus
epidermidis Biofilms, Antimicrobial Agents and Chemotherapy, 46 (3), 900–903
32
Ziebuhr, W., Krimmer, V., Rachid, S., Loßner, I., Got, F., 1999, A novel mechanism
of phase variation of virulence in Staphylococcus epidermidis : evidence for
control of the polysaccharide intercellular adhesin synthesis by alternating
insertion and excision of the insertion sequence element IS256, Molecular
Microbiology, 32 (2), 345–356